dc.contributor.author |
Sudbury, Eva L. |
|
dc.contributor.author |
Otero Vegas, Larissa |
|
dc.contributor.author |
Tebruegge, Marc |
|
dc.contributor.author |
Messina, Nicole L. |
|
dc.contributor.author |
Seas Ramos, Carlos Rafael |
|
dc.contributor.author |
Montes Delgado, Martin |
|
dc.contributor.author |
Rios, Julia |
|
dc.contributor.author |
Germano, Susie |
|
dc.contributor.author |
Gardiner, Kaya |
|
dc.contributor.author |
Clifford, Vanessa |
|
dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.contributor.author |
Curtis, Nigel |
|
dc.date.accessioned |
2019-07-04T17:00:19Z |
|
dc.date.available |
2019-07-04T17:00:19Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/6863 |
|
dc.description.abstract |
The tuberculin skin test and interferon-gamma release assays have limitations in diagnosing tuberculosis (TB), particularly in children. This study investigated the performance of candidate M. tuberculosis-specific cytokine biomarkers for TB in children in a TB-endemic setting. A total of 237 children with a household contact with smear-positive pulmonary TB were recruited. Importantly, a group of children with illnesses other than TB (sick controls) was included to assess specificity. Median IFN-ɣ, IL-1ra, IL-2, IL-13, IP-10, MIP-1β and TNF-α responses were significantly higher in children with active TB and latent TB infection (LTBI) than in both healthy and sick control children. Three of these cytokines – IL-2, IL-13 and IP-10 – showed better performance characteristics than IFN-ɣ, with IL-2 achieving positive and negative predictive values of 97.7% and 90.7%, respectively. Furthermore, IL-1ra and TNF-α responses differed significantly between active TB and LTBI cases, suggesting that they may be stage-specific biomarkers. Our data indicate that incorporating these biomarkers into future blood-based TB assays could result in substantial performance gains. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
adolescent |
en_US |
dc.subject |
adult |
en_US |
dc.subject |
aged |
en_US |
dc.subject |
area under the curve |
en_US |
dc.subject |
Article |
en_US |
dc.subject |
blood sampling |
en_US |
dc.subject |
child |
en_US |
dc.subject |
clinical assessment |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
cytokine |
en_US |
dc.subject |
Cytokine biomarkers |
en_US |
dc.subject |
cytokine response |
en_US |
dc.subject |
diagnostic test accuracy study |
en_US |
dc.subject |
endemic disease |
en_US |
dc.subject |
female |
en_US |
dc.subject |
gamma interferon |
en_US |
dc.subject |
gamma interferon inducible protein 10 |
en_US |
dc.subject |
human |
en_US |
dc.subject |
infant |
en_US |
dc.subject |
Interferon-gamma release assay |
en_US |
dc.subject |
interleukin 1 receptor blocking agent |
en_US |
dc.subject |
interleukin 13 |
en_US |
dc.subject |
interleukin 2 |
en_US |
dc.subject |
latent tuberculosis |
en_US |
dc.subject |
macrophage inflammatory protein 1beta |
en_US |
dc.subject |
major clinical study |
en_US |
dc.subject |
male |
en_US |
dc.subject |
multicenter study |
en_US |
dc.subject |
Mycobacterium tuberculosis |
en_US |
dc.subject |
predictive value |
en_US |
dc.subject |
priority journal |
en_US |
dc.subject |
sensitivity and specificity |
en_US |
dc.subject |
sputum smear |
en_US |
dc.subject |
TB-endemic |
en_US |
dc.subject |
Tuberculin skin test |
en_US |
dc.subject |
tuberculin test |
en_US |
dc.subject |
tuberculosis |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
tumor necrosis factor |
en_US |
dc.title |
Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.jctube.2019.100102 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#1.06.01 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.07 |
|
dc.relation.issn |
2405-5794 |
|